Globus Medical Stock Beneish M Score
| GMED Stock | USD 50.55 0.18 0.36% |
Globus | Beneish M Score |
At this time, it appears that Globus Medical is an unlikely manipulator. The earnings manipulation may begin if Globus Medical's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Globus Medical executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Globus Medical's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.29
Beneish M Score - Unlikely Manipulator
Globus Medical Beneish M-Score Indicator Trends
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Globus Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Net Receivables | 530.1 M | 504.9 M |
|
| |||||
| Total Revenue | 1.6 B | 1.6 B |
|
| |||||
| Total Assets | 5.3 B | 5.1 B |
|
| |||||
| Total Current Assets | 2 B | 1.9 B |
|
| |||||
| Non Current Assets Total | 3.3 B | 3.2 B |
|
| |||||
| Property Plant Equipment | 146.5 M | 280.3 M |
|
| |||||
| Depreciation And Amortization | 152 M | 144.7 M |
|
| |||||
| Selling General Administrative | 675.6 M | 643.4 M |
|
| |||||
| Total Current Liabilities | 412 M | 392.3 M |
|
| |||||
| Non Current Liabilities Total | 730.6 M | 695.8 M |
|
| |||||
| Short Term Debt | 11.4 M | 12 M |
|
| |||||
| Operating Income | 153.7 M | 133.1 M |
|
| |||||
| Total Cash From Operating Activities | 156.4 M | 243.5 M |
|
| |||||
| Long Term Investments | 71.7 M | 75.4 M |
|
| |||||
| Gross Profit Margin | 0.85 | 0.6505 |
|
|
Globus Medical Beneish M-Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Globus Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Globus Medical in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Globus Medical's degree of accounting gimmicks and manipulations.
Click cells to compare fundamentals
About Globus Medical Beneish M Score
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Depreciation And Amortization |
|
Globus Medical Earnings Manipulation Drivers
Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Globus Medical. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Receivables | 162.4M | 148.1M | 165.7M | 217.3M | 504.9M | 530.1M | |
| Total Revenue | 785.4M | 789.0M | 958.1M | 1.0B | 1.6B | 1.6B | |
| Total Assets | 1.5B | 1.7B | 2.0B | 2.1B | 5.1B | 5.3B | |
| Total Current Assets | 687.5M | 821.8M | 864.5M | 983.3M | 1.9B | 2.0B | |
| Net Debt | (193.2M) | (234.6M) | (188.0M) | (144.5M) | 53.1M | 55.8M | |
| Short Term Debt | 74.7M | 88.7M | 94.4M | 2.5M | 12.0M | 11.4M | |
| Operating Income | 172.0M | 111.4M | 172.0M | 228.0M | 133.1M | 153.7M | |
| Investments | (45.7M) | (20.2M) | (284.6M) | (4.9M) | (78.1M) | (82.0M) |
About Globus Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Globus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Globus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Globus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Globus Medical Investors Sentiment
The influence of Globus Medical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Globus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Globus Medical's public news can be used to forecast risks associated with an investment in Globus. The trend in average sentiment can be used to explain how an investor holding Globus can time the market purely based on public headlines and social activities around Globus Medical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Globus Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Globus Medical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Globus Medical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Globus Medical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Globus Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Globus Medical's short interest history, or implied volatility extrapolated from Globus Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Globus Medical Piotroski F Score and Globus Medical Altman Z Score analysis. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share 1.07 | Revenue Per Share 13.87 | Quarterly Revenue Growth 1.246 | Return On Assets 0.0477 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.